Primary cell-mediated lympholysis response to a maternally transmitted antigen by unknown
Brief Definitive Report 
PRIMARY  CELL-MEDIATED  LYMPHOLYSIS  RESPONSE  TO  A 
MATERNALLY  TRANSMITTED  ANTIGEN* 
By ROGER  SMITH  III, DAVID P.  HUSTON, AND ROBERT  R.  RICH 
From the Howard Hughes Medical Institute Laboratory and the Departments of Microbiolog)~ and 
hnmunology, and of Medicine, Baylor College of Medicine; and The Methodist Hospital, 
Houston, Texas 77030 
Cytotoxic T  lymphocytes (CTL)  generated by priming and  restimulating  murine 
splenocytes with H-2-compatible allogeneic cells are generally restricted to recognizing 
minor histocompatibility antigens on target cells of the same H-2 haplotype (1). Two 
important  exceptions  to  the  rule  of H-2  restriction  are  the  recognition  of class  I 
antigens  encoded  in  the  Qa-Tla  region  of  the  17th  chromosome  (2-8)  and  the 
recognition  of a  maternally  transmitted  antigen  (Mta)  in  secondary cell-mediated 
lympholysis (CML)  responses  of NZB  mice  (9).  In  most  protocols,  significant  H-2- 
unrestricted cytolysis is only observed in secondary responses  (2,  3, 6),  but  the  NZB 
strain is unique in that such CTL can be generated without prior in vivo priming (5, 
10-13).  We  previously  reported  that  the  NZB  primary  CML  response  to  H-2 d 
stimulators is predominantly H-2-unrestricted and specific for the Q a- 1.2 determinant. 
However,  when  NZB  mice  are  first  primed  in  vivo  to  H-2-compatible  cells,  H-2- 
unrestricted  lysis of target  cells  that  do  not  express  Qa-l.2  is  also  observed  (9,  our 
unpublished observations). Genetic analysis by Fischer Lindahl et al. (9) demonstrated 
that  the  additional  antigen  recognized  by  the  NZB  secondary  CTL  is  maternally 
transmitted, hence the designation Mta. 
Although other  investigators  have  confirmed our  fnding  that  the  primary  NZB 
CML  response  to H-2 d  stimulators  is  predominantly  Q a-l.2  specific  (5,  9,  13,  14), 
some also observed low levels of lysis on Qa-l", non-H-2 d target cells (10,  1 1,  13,  14). 
An additional observation that has been particularly difficult to interpret,  in view of 
our  previous  findings  of Qa-l.2-specific  responses,  is  that  heterozygous  Qa-1 a/b  F1 
CTL [e.g., (NZB ×  B 10.D2)F~ 1 anti-BALB/c] lysed target cells in an H-2-unrestricted 
manner  (13,  15).  Because,  for genetic reasons,  it  appeared  quite  unlikely  that  Qa-1- 
encoded  determinants  were  recognized  in  such  cultures,  the  nature  of the  target 
antigen for this H-2-unrestricted response was unclear. Our interest in H-2-unrestricted 
CML responses and in the genetics of NZB hyperresponsiveness led us to investigate 
possible  differences  in  specificities  of NZB  and  F1  CTL  recovered  from  a  primary 
culture  with  H-2-compatible  stimulators.  We  found  that  a  major  target  antigen 
recognized  by  the  Qa-l-heterozygous F1  CTL  was  Mta,  thus  constituting  the  first 
demonstration that Mta can stimulate a  primary CML response. 
Materials and Methods 
Mice.  BALB/c mice were obtained frorn the Department of Cell Biology, Baylor College of 
Medicine, Houston, TX. B6-Tla" mice were bred in our colony. All other mice were obtained 
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from The Jackson Laboratory, Bar Harbor,  ME,  or were bred  in our colony from Jackson 
Laboratory breeding stock. All mice used as donors of responder and stimulator cells were sex 
matched. Responder cells were obtained from mice 6-14 wk of age. 
In Vitro Generation of CTL.  CTL were generated using a modification of previously described 
procedures (12).  Preliminary experiments demonstrated that higher levels of cytolysis could be 
obtained by increasing the concentration of stimulator cells from our standard density of 5 × 
105/ml  to a  density of 2-3  ×  106/ml.  Thus,  unprimed responder cells and  irradiated H-2- 
compatible stimulator cells were mixed in equal numbers at a  final cell density of 4-6 ×  106/ 
ml, and cultured for 6 d  at 37°C  in a  humidified atmosphere of 5% CO2 in air. The culture 
medium was Eagle's minimum essential medium with Hanks' balanced salt solution, supple- 
mented as described (12),  with 5% fetal calf serum (Gibco Laboratories, Grand Island, NY), 
and 2 ×  10 -2 M  2-mercaptoethanol (Eastman Kodak Co., Rochester, NY). 
Assay for CTL Activity.  Target cells were ~lCr-labeled  concanavalin A-stimulated  spleen cells, 
prepared as previously described (12).  Targets were plated at a  density of 20,000 viable cells 
per well in 96-well round-bottomed tissue culture plates (Flow Laboratories, Rockville, MD). 
Cold targets were concanavalin A blasts prepared in the same manner, but not labeled. Effector 
cells and cold targets were adjusted for viability and added, in doubling dilutions, to the wells 
containing hot targets. The cells were incubated for 4-6 h  at  37°C  and harvested using the 
Titertek Supernatant Collection System (Flow Laboratories). Data are expressed as:  percent 
net Cr release -- ([experimental release -  spontaneous release]/[maximum release -  sponta- 
neous release]) ×  100, where the spontaneous release is the activity released from hot  target 
cells in medium alone, and the maximum release is the activity released from hot target cells 
lysed with 0.5% sodium dodecyl sulfate, or by three cycles of freezing and thawing. 
Results 
We first compared the specificity of NZB  and  (NZB  ×  B10.D2)F1  primary CTL 
responding to H-2-compatible stimulators  (Fig.  1).  As previously reported  (12),  the 
NZB CML  response to H-2 a stimulator cells was Qa-1.2 specific, as demonstrated by 
the differential lysis of targets from the Qa-Tla region congenic pair B6 (//-2 b, Qa-16) 
and B6-Tla a (H-2 b,  Qa-1 a)  (Fig.  1 A). The greater degree of lysis of BALB/c targets 
than of B6 targets is consistent with H-2-restricted, minor histocompatibility antigen- 
specific cytolysis, as  reported  by  others  (10,  11,  13).  We  confirmed  that  (NZB  × 
B 10.D2)Fx anti-BALB/c CTL can also be generated in a  primary response, and the 
the cytolysis was H-2-unrestricted, with lysis of both H-2 b targets tested (Fig.  1 B). As 
expected, the  Qa-l-heterozygous  responders did  not  recognize Qa-l.2  on  the  target 
cells, as demonstrated by equivalent levels of lysis of B6 and B6-Tla ~ targets. Similar 
to the NZB  response, H-2orestricted, minor histocompatibility antigen-specific CTL 
may have been generated (compare lysis of BALB/c and B6 or B6-Tla ~ targets, Fig. 
1 B), but this was not observed in all experiments. 
Because of the H°2-unrestricted nature of the F1 primary CML  response, and the 
report of secondary H-2-unrestricted lysis of cells bearing a  maternally transmitted 
antigen  (9), we asked whether  Qa-l-heterozygous  F1 CTL  could recognize Mta  in a 
primary response.  To  study  Mta-specific CTL,  we assayed for  lysis of targets  from 
reciprocal F1 females that share the same complement of chromosomes, but  differ in 
their expression of Mta.  Fischer Lindahl et  al.  (9)  reported that  Mta + mothers bear 
Mta + progeny, regardless of the male partner's phenotype. Similarly, Mta-  mothers 
bear only Mta-  progeny. All inbred strains typed by Fischer Lindahl et  al., except 
NZB, z  were  Mta +.  Thus,  (NZB  X  B10.D2)F1  mice  are  Mta-,  but  the  reciprocal 
20utbred  NMRI  mice  are also  Mta-.  However,  two  sublines  of the  NZB  strain, NZB/Fiill and 
NZB/BIPt, typed positive for Mta.  In all experiments  shown, we used the  Mta- subline  NZB/BINJ. 
Similar results have been obtained with  the NZB/N subline, which was not typed by Fischer Lindahl 
et al. (9). 1868  SMITH  ET  AL.  BRIEF  DEFINITIVE REPORT 
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FIo.  1.  NZB  (A) or (NZB X B10.D2)F,  (B) splenocytes were stimulated in vitro with irradiated 
BALB/c splenocytes and assayed for cytotoxicity against a panel of  S'Cr-labeled targets. Spontaneous 
release values were 5-11% of the maximum release for each target. The vertical bars represent 1 SE 
of the mean of triplicate determinations. 
(B10.D2 ×  NZB)F1 mice are Mta  +. The use of females as the donors of target cells 
rules out sex-linked transmission of the target antigen for the CTL. Fig.  2 A  depicts 
the  results  of  such  an  experiment  in  which  primary  (NZB  ×  B10.D2)F1  anti- 
BALB/c CTL were assayed on a  panel of hot targets. The Mta  ÷ targets, (B 10.D2 × 
NZB)Fz and (B10.BR x  NZB)Fz, were lysed to the same extent as other Mta  + targets 
used in this experiment, but the reciprocal Mta- FI targets, (NZB ×  B10.D2)Fz and 
(NZB ×  B10.BR)F1, were lysed at a  much lower level.  On the other hand, differen- 
tial lysis of reciprocal F1 targets was not observed when the CTL were generated from 
(B10.D2 ×  NZB)FI anti-BALB/c cultures, in which both responder and stimulator 
cells were Mta  + (Fig.  2 B). In addition, the Mta  + F1 CTL did not lyse the non-H-2 a 
targets (B6 and B6-Tlaa). The low levels of lysis on syngeneic and other H-2 a targets 
was observed in approximately one-half of our experiments with the Fa responders. 
This may represent H-2-restricted lysis specific for serum components or for virus on 
the blasts used as targets. 
Although the lysis of H-2 b targets (B6 and B6-Tla a) in Fig. 2A demonstrated 1-1-2- 
unrestricted lysis,  it  was important to demonstrate specifically that  the  lysis  of the 
Mta  ÷ Wl targets was not restricted by the H-2a-encoded determinants shared with the 
effectors. Cold target inhibition experiments were performed to address this issue (Fig. 
3).  Lysis of the 51Cr-labeled target, C57BL/10 (B10, H-2 b, Mta+), was inhibited by 
cold targets from the Mta  + (B10.D2 ×  NZB)FI, but not by those from Mta-  (NZB 
X B 10.D2)F1. Thus, the relevant antigen recognized by H-2-unrestricted CTL on the 
B 10 targets is the same as that recognized on the Mta  + Fa targets. 
Discussion 
The  nature of the  target  antigens  for NZB  anti-H-2 a primary CTL has  been  a 
subject of controversy. Although most investigators agree that Qa-1.2 is a major target 
antigen and  that  H-2-restricted minor histocompatibility antigen-specific lysis  may SMITH  ET AL.  BKIEF  DEFINITIVE REPORT  1869 
60 
50 
40 
3.  3o 
~  2O 
z 
10 
Target  H-2  Oa-1 Mta 
(BIO. BRxNZ  B) F  1  k/d  a/a  + 
BALBIc  d  b  + 
(BIO. D2xNZB) F  1  d/d  b/a  + 
B6-TIja  b  a  + 
B6  b  b  + 
~ 
NZB  d  a 
(NZBxBIO. BRIF  I  (Ilk  ala  - 
(NZBxBIO.D2) F  I  d/d  a/b  - 
l0  20  40  80 
Target 
BALBtc 
~  ~BIO.  02xNZBI FI 
I BI0. BRxNZ  B~ F  1 
(NNZzBBx  ~10.  BR, F  1 
NZBxB10 O21 F  1 
~  ~. Tlaa 
I  I  I  l 
10  20  40  80 
Effector  /  Target  Ratio 
H-2  Oa-l  Mta 
d  b  * 
dld  bla  + 
k/d  ala  + 
d  a 
dlk  ala 
dd  ao 
b  a  + 
b  b  * 
Fro.  2.  (NZB  X B10.D2)F1  (A) or (B10.D2  X NZB)F1  (B) splenocytes  were stimulated in vitro 
with irradiated BALB/c splenocytes  and  assayed  for cytotoxicity against a  panel of 51Cr-labeled 
target cells.  Spontaneous release values were 19-27%  of the maximum release for each target. The 
vertical bars represent 1 SE of the mean of triplicate determinations. 
50 
4O 
30 
z 
20 
10 
Cold Target  H-2  Mta 
(NZBx B10,  02)fl  did 
(BIO. D2 x NZB)F1  did  + 
BIO  b  + 
I 
Cold/Hot Ratio 
Fzo.  3.  (NZB X BI0.D2)F1  splenocytes  were stimulated in vitro with irradiated BALB/c spleno- 
cytes, and assayed  at an effector/target ratio of 64:1 against SlCr-labeled  B10 targets and varying 
densities of unlabeled targets.  In the absence of unlabeled inhibitors, net SlCr release was 52%. The 
spontaneous release was 28% of the maximum release. The vertical bars represent 1 SE of the mean 
of triplicate determinations. 
occur, not all data  can be accounted  for by these findings.  A  particularly  intriguing 
observation is that  H-2-unrestricted,  non-Qa-l.2-specific cytolysis has  been  detected 
in  (NZB  ×  B10.D2)F1  responses  (13,  15).  The  data  presented  in  this report  strongly 
suggest that  Mta  is a  major target antigen for such responses. The differential lysis of 1870  SMITH  ET AL.  BRIEF  DEFINITIVE REPORT 
reciprocal  F1  target  cells  by H-2-unrestricted CTL  demonstrates specificity for  an 
antigen that is indistinguishable from that described by Fischer Lindahl et al. (9)  for 
NZB secondary CML responses. In that report, the investigators did not detect Mta- 
specific  lysis  in  NZB  primary CML  responses.  However,  other  investigators  have 
reported H-2-unrestricted lysis of Qa- l a target cells by primary NZB CTL (10,  11,  13, 
14). We  observed low  levels of such  lysis  in  approximately one-third  of our  NZB 
primary CML  responses  to  H-2-compatible stimulators.  In  those  experiments,  we 
detected  greater  lysis on  Mta +  (B10.A  ×  NZB)F1  targets  than  on  Mta-  (NZB  × 
B10.A)F1  targets  (our unpublished  observations). Thus,  Mta-specific CTL can also 
account for the low level of lysis detected on Qa-1 a, non_H_2 a target cells in the NZB 
primary CML response. In all paired comparisons of NZB and  (NZB  X  B10.D2)F1 
responses, Mta-specific lysis by the Qa-1 a/b F1 CTL was always greater than that by 
the NZB CTL (compare lysis of the B6-Tla a target in panels A and B, Fig.  1). Absence 
of  foreign  Qa-1  determinants  in  the  stimulator  population  may  therefore  be  a 
requirement for generating a strong primary Mta-specific response, 
The finding that the Qa-1 heterozygous (NZB ×  B 10.D2)F1 hybrids respond to Mta 
may clarify much of the controversy regarding the specificity of the  NZB  primary 
CML response. When NZB cells are stimulated with H-2-compatible stimulators, the 
major  target  antigen  is  Qa-l.2,  although  Mta-specific  and  H-2-restricted  minor 
antigen-specific lysis may also occur. The same pattern holds for Qa-l%homozygous 
F1 responders (e.g., [NZB ×  B 10.BR)F1;  our unpublished observations]. However, if 
the  F1  responder is  a  Qa-1 heterozygote, the  specificity depends  on  whether  the  Fa 
expresses Mta.  H-2-restricted  lysis  occurs  regardless  of the  Mta  phenotype  of the 
responder, and is the only reactivity seen for the Mta + responder.  But  for the Mta- 
F1, H-2-unrestricted, Mta-specific lysis is the major component of the response. 
That  the  NZB  response is  directed  against  a  complex set  of target  antigens  has 
important  implications  for  studying  the  genetics  of  NZB  hyperreactivity  in  the 
primary CML response. Because F1 and backcross mice may not recognize as foreign 
the same antigenic  determinants that  the parental  NZB mice recognize, one might 
mistake genes, such as Qa-l, that determine antigenic disparity for those that  deter- 
mine hyperreactivity. The finding that one of the target antigens does not segregate 
in Mendelian  fashion makes such considerations even more important.  Davidson et 
al. (13), studying the response of (NZB ×  B 10.D2)F1 mice and their backcrosses to the 
B 10.D2 parent, concluded that two genes control the response to non-Qa-1 antigens, 
and that one or both of these genes is semidominant, because the response of the F1 
mice was intermediate between that of the NZB and B 10.D2 parents. An alternative 
explanation for the  intermediate level of F1  responsiveness is  that  the  F1  and  NZB 
CTL respond  to  different  stimulator cell  antigens,  because  the  F1  mice were  Qa-1 
heterozygotes. The inability of those particular F1 mice to recognize the major target 
antigen  for the parental  NZB  response, rather  than  gene dosage effects, may have 
caused the  lower magnitude  of the  F1  response.  When  the  F1  generation  is  Qa-1  a- 
homozygous  [e.g.,  (NZB  ×  B10.BR)F@  the  response  is  Qa-l.2-specific  and  the 
magnitude is equal to that of the NZB parent, suggesting that hyperresponsiveness to 
Qa-l.2  is  a  dominant  effect  (our  unpublished  observations). Thus,  in  studying  the 
genetics of NZB hyperreactivity in the primary CML response, it is necessary to take 
into account  not  only the  magnitude of the response, but  also whether the  Fa  and 
backcross mice are capable of recognizing Qa-1.2 or Mta as foreign determinants on 
the stimulator cells. SMITH  ET AL.  BRIEF DEFINITIVE REPORT  1871 
Summary 
Mta-specific cytotoxic T  lymphocytes (CTL) can be generated in primary cultures 
of (NZB ×  B 10.D2) F1 spleen cells with H-2-compatible BALB/c stimulator cells. The 
CTL  lyse reciprocal Mta +  (B 10.D2  ×  NZB)Fa as well as H-2-disparate targets, such 
as B10, B6, and B6-Tlaa;  they do not  lyse targets from NZB or any F1 hybrid of an 
NZB mother. The lysis of51Cr-labeled B I0 targets is completely inhibited by unlabeled 
targets from  Mta +  (B10.D2  ×  NZB)F1,  but  not  from  the  reciprocal Mta-  F1,  thus 
demonstrating H-2-unrestricted lysis of Mta. 
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